|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1999-5-25
|
|
pubmed:abstractText |
We evaluated the effect of hyperfractionated accelerated radiotherapy combined with low dose radiosensitisers followed by standard dose chemotherapy in the treatment of unresectable stage III non small cell lung cancer (NSCLC).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0169-5002
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
23
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
19-30
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10100143-Adult,
pubmed-meshheading:10100143-Aged,
pubmed-meshheading:10100143-Antineoplastic Agents, Phytogenic,
pubmed-meshheading:10100143-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:10100143-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:10100143-Cisplatin,
pubmed-meshheading:10100143-Combined Modality Therapy,
pubmed-meshheading:10100143-Dose Fractionation,
pubmed-meshheading:10100143-Female,
pubmed-meshheading:10100143-Follow-Up Studies,
pubmed-meshheading:10100143-Humans,
pubmed-meshheading:10100143-Lung Neoplasms,
pubmed-meshheading:10100143-Male,
pubmed-meshheading:10100143-Middle Aged,
pubmed-meshheading:10100143-Neoplasm Staging,
pubmed-meshheading:10100143-Pilot Projects,
pubmed-meshheading:10100143-Prospective Studies,
pubmed-meshheading:10100143-Survival Rate,
pubmed-meshheading:10100143-Treatment Outcome,
pubmed-meshheading:10100143-Vinblastine
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Concurrent chemotherapy with hyperfractionated accelerated thoracic irradiation in stage III non-small cell lung cancer.
|
|
pubmed:affiliation |
Cancer Care Ontario, Ottawa Regional Cancer Centre, Ont, Canada.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study
|
